Temporal Dynamics of Neuronal Activation by Channelrhodopsin-2 and TRPA1 Determine Behavioral Output in Drosophila Larvae SR Pulver, SL Pashkovski, NJ Hornstein, PA Garrity, LC Griffith Journal of neurophysiology 101 (6), 3075-3088, 2009 | 312 | 2009 |
Ribosome profiling reveals a cell-type-specific translational landscape in brain tumors C Gonzalez, JS Sims, N Hornstein, A Mela, F Garcia, L Lei, DA Gass, ... Journal of Neuroscience 34 (33), 10924-10936, 2014 | 125 | 2014 |
Widespread alterations in translation elongation in the brain of juvenile Fmr1 knockout mice SD Sharma, JB Metz, H Li, BD Hobson, N Hornstein, D Sulzer, G Tang, ... Cell reports 26 (12), 3313-3322. e5, 2019 | 70 | 2019 |
Ligation-free ribosome profiling of cell type-specific translation in the brain N Hornstein, D Torres, S Das Sharma, G Tang, P Canoll, PA Sims Genome biology 17, 1-15, 2016 | 61 | 2016 |
Optogenetics in the teaching laboratory: using channelrhodopsin-2 to study the neural basis of behavior and synaptic physiology in Drosophila SR Pulver, NJ Hornstein, BL Land, BR Johnson Advances in physiology education 35 (1), 82-91, 2011 | 46 | 2011 |
Channelrhodopsin2 mediated stimulation of synaptic potentials at Drosophila neuromuscular junctions NJ Hornstein, SR Pulver, LC Griffith JoVE (Journal of Visualized Experiments), e1133, 2009 | 26 | 2009 |
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44 AL Cummings, J Gukasyan, HY Lu, T Grogan, G Sunga, CM Fares, ... Nature cancer 1 (12), 1167-1175, 2020 | 24 | 2020 |
Efficacy of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma: a randomized crossover trial JP Shen, AM Yousef, FA Zeineddine, MA Zeineddine, RS Tidwell, ... JAMA Network Open 6 (6), e2316161-e2316161, 2023 | 10 | 2023 |
Factors associated with hospitalization among breast cancer patients with COVID-19: a diverse multi-center Los Angeles cohort study N Kathuria-Prakash, L Antrim, N Hornstein, AW Sun, IM Kang, NV Baclig, ... Clinical breast cancer 22 (4), e558-e566, 2022 | 6 | 2022 |
Widespread alterations in translation elongation in the brain of juvenile Fmr1 knockout mice. Cell Rep. 26, 3313–3322. e5 S Das Sharma, JB Metz, H Li, BD Hobson, N Hornstein, D Sulzer, G Tang, ... | 6 | 2019 |
High-throughput translational profiling with riboPLATE-seq JB Metz, NJ Hornstein, SD Sharma, J Worley, C Gonzalez, PA Sims Scientific Reports 12 (1), 5718, 2022 | 5 | 2022 |
Nivolumab treatment of Burkitt lymphoma: a case report BS Colton, N Hornstein, J Timmerman, S Larson, J Glaspy Annals of Internal Medicine 174 (4), 567-568, 2021 | 4 | 2021 |
A prospective randomized crossover trial of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma JP Shen, AM Yousef, FA Zeineddine, MA Zeineddine, RS Tidwell, ... medRxiv, 2022.12. 06.22283164, 2022 | 2 | 2022 |
The natural history of a patient with COVID-19 pneumonia and silent hypoxemia N Hornstein, GM Jaffe, K Chuang, J Betancourt, GWS Hoo Federal Practitioner 38 (4), 184, 2021 | 1 | 2021 |
Efficacy and safety of atezolizumab and bevacizumab in appendiceal adenocarcinoma NJ Hornstein, MA Zeineddine, BB Gunes, AJ Pellatt, M Knafl, H Zhu, ... Cancer Research Communications 4 (5), 1363-1368, 2024 | | 2024 |
Cell-type-specific gene programs suggest immune and stromal drivers of relapse in colorectal cancer NJ Hornstein, M Wang, A Yousef, S Chowdhury, F Zeineddine, ... Cancer Research 84 (6_Supplement), 881-881, 2024 | | 2024 |
Identification of colorectal cancer cell stemness from single-cell RNA sequencing K Lin, S Chowdhury, MA Zeineddine, FA Zeineddine, NJ Hornstein, ... Molecular Cancer Research, OF1-OF10, 2024 | | 2024 |
Single cell transcriptomic profiling of appendiceal adenocarcinoma to identify rare tumor cells and a myeloid-enriched tumor microenvironment (TME). BB Gunes, NJ Hornstein, M Wang, S Chowdhury, MMG Yousef, ... Journal of Clinical Oncology 42 (3_suppl), 760-760, 2024 | | 2024 |
27P Extending a classification system for atypical BRAF mutations to improve targeted therapies in colorectal cancer cells AB Madduri, Y Liu, BG Nelson, KE Sanders, D Wang, N Hornstein, J Shen Annals of Oncology 34, S195, 2023 | | 2023 |
Abstract CT148: Efficacy, safety, and biomarker analysis of combined MEK (Cobimetinib) and PD-L1 (Atezolizumab) inhibition (COTEZO) in advanced small bowel adenocarcinoma (SBA) N Hornstein, JP Shen, AJ Pellatt, S Liu, M Knafl, AF Willett, H Zhu, ... Cancer Research 83 (8_Supplement), CT148-CT148, 2023 | | 2023 |